Bain Capital Life Sciences Fund, L.p. - Net Worth and Insider Trading
Bain Capital Life Sciences Fund, L.p. Net Worth
The estimated net worth of Bain Capital Life Sciences Fund, L.p. is at least $38 Million dollars as of 2024-11-13. Bain Capital Life Sciences Fund, L.p. is the 10% Owner of Annexon Inc and owns about 5,701,926 shares of Annexon Inc (ANNX) stock worth over $38 Million. Details can be seen in Bain Capital Life Sciences Fund, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bain Capital Life Sciences Fund, L.p. has not made any transactions after 2023-05-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bain Capital Life Sciences Fund, L.p.
Bain Capital Life Sciences Fund, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bain Capital Life Sciences Fund, L.p. owns 7 companies in total, including Annexon Inc (ANNX) , Arcutis Biotherapeutics Inc (ARQT) , and Aptinyx Inc (APTX) among others .
Insider Ownership Summary of Bain Capital Life Sciences Fund, L.p.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ANNX | Annexon Inc | 2023-05-25 | 10 percent owner |
ARQT | Arcutis Biotherapeutics Inc | 2020-01-30 | 10 percent owner |
APTX | Aptinyx Inc | 2020-01-14 | 10 percent owner |
2019-11-19 | 10 percent owner | ||
2018-07-19 | 10 percent owner | ||
2017-09-19 | 10 percent owner | ||
2021-07-14 | 10 percent owner |
Bain Capital Life Sciences Fund, L.p. Latest Holdings Summary
Bain Capital Life Sciences Fund, L.p. currently owns a total of 1 stock. Bain Capital Life Sciences Fund, L.p. owns 5,701,926 shares of Annexon Inc (ANNX) as of May 25, 2023, with a value of $38 Million.
Latest Holdings of Bain Capital Life Sciences Fund, L.p.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ANNX | Annexon Inc | 2023-05-25 | 5,701,926 | 6.62 | 37,746,750 |
Holding Weightings of Bain Capital Life Sciences Fund, L.p.
Bain Capital Life Sciences Fund, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Bain Capital Life Sciences Fund, L.p. has made a total of 2 transactions in Annexon Inc (ANNX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Annexon Inc is the acquisition of 300,000 shares on May 25, 2023, which cost Bain Capital Life Sciences Fund, L.p. around $639,000.
Insider Trading History of Bain Capital Life Sciences Fund, L.p.
- 1
Bain Capital Life Sciences Fund, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Bain Capital Life Sciences Fund, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bain Capital Life Sciences Fund, L.p. is 32.52%. GuruFocus also compares Bain Capital Life Sciences Fund, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Bain Capital Life Sciences Fund, L.p. within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bain Capital Life Sciences Fund, L.p.'s insider trading performs compared to the benchmark.
Performance of Bain Capital Life Sciences Fund, L.p.
Bain Capital Life Sciences Fund, L.p. Ownership Network
Ownership Network List of Bain Capital Life Sciences Fund, L.p.
Ownership Network Relation of Bain Capital Life Sciences Fund, L.p.
Bain Capital Life Sciences Fund, L.p. Owned Company Details
What does Annexon Inc do?
Who are the key executives at Annexon Inc?
Bain Capital Life Sciences Fund, L.p. is the 10 percent owner of Annexon Inc. Other key executives at Annexon Inc include EVP & Chief Innovation Officer Ted Yednock , EVP & Chief Business Officer Michael Overdorf , and EVP & Chief Financial Officer Jennifer Lew .
Annexon Inc (ANNX) Insider Trades Summary
Over the past 18 months, Bain Capital Life Sciences Fund, L.p. made 1 insider transaction in Annexon Inc (ANNX) with a net purchase of 300,000. Other recent insider transactions involving Annexon Inc (ANNX) include a net sale of 74,985 shares made by Ted Yednock , a net purchase of 22,400 shares made by William H. Carson , and a net sale of 6,563 shares made by Jennifer Lew .
In summary, during the past 3 months, insiders sold 26,408 shares of Annexon Inc (ANNX) in total and bought 6,400 shares, with a net sale of 20,008 shares. During the past 18 months, 92,392 shares of Annexon Inc (ANNX) were sold and 672,400 shares were bought by its insiders, resulting in a net purchase of 580,008 shares.
Annexon Inc (ANNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Annexon Inc Insider Transactions
Bain Capital Life Sciences Fund, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Bain Capital Life Sciences Fund, L.p.. You might contact Bain Capital Life Sciences Fund, L.p. via mailing address: 200 Clarendon Street, Boston Ma 02116.